Debate over labeling certain cancers as 'benign' or 'premalignant' instead of 'cancer' due to stigma and fear. Experts weigh in on potential impact ...
In 4Q24, our ninth year in operation, we crossed $10M in AUM, a milestone of progress. Who were the top performers and detractors? Click here to find out.
Group sales grew by 7%1 at constant exchange rates (CER; 3% in CHF), driven by strong demand for both medicines and diagnostics.Excluding COVID-19, Group sales increased by 9%.
Dr Agarwal IPO opened for subscription on January 29. The firm holds approximately 25% market share in India and plans to allocate funds for debt repayment and acquisitions. The IPO price band is set ...